BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The resulting BCR::ABL1 fusion, located on the Ph chromosome, encodes a chimeric BCR::ABL1 protein with deregulated tyrosine kinase activity that is the primary driver of the pathogenesis of CML [4].